CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor...

Company's Connected Platform on Full Display in Booth 1426 at the 2025 NADA Show This Month CHICAGO, Jan. 22, 2025 /PRNewswire/ -- Cars.com Inc. (NYSE: CARS) (d/b/a "Cars Commerce"), an...

Pelareorep combination therapy shows continued meaningful improvement over checkpoint inhibitors alone in anal cancer patients Pelareorep-based therapy demonstrates strong safety profile with new...

Epson to Demonstrate Better Ways to Display: Flexible Solutions for Immersive Learning and Enhanced Collaboration LOS ALAMITOS, Calif., Jan. 22, 2025 /PRNewswire/ -- Advancements in educational...